RELAPSED HODGKIN LYMPHOMA

Clinical trials for RELAPSED HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to tame Tough-to-Treat lymphomas

Disease control Recruiting now

This study is testing whether combining two existing drugs—pembrolizumab and ATRA—can help control Hodgkin lymphoma or B-cell non-Hodgkin lymphoma that has returned or stopped responding to other treatments. It will enroll about 24 adults to see if the combination is safe and can…

Matched conditions: RELAPSED HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: Rita Assi • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

RELAPSED HODGKIN LYMPHOMA

Get alerted when new RELAPSED HODGKIN LYMPHOMA trials appear

New drug duo aims to tame Tough-to-Treat lymphomas